Platelet-derived growth factor, transforming growth factor-β, and connective tissue growth factor in a porcine bronchial model of obliterative bronchiolitis

Experimental Lung Research

Volumn 33, Issue 6, 2007, Pages 303-320

  Alho, Hanni S ^a,b   Maasilta, Paula K ^a   Vainikka, Tiina ^a   Salminen, Ulla Stina ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

CTGF; Experimental lung transplantation; Imatinib; Obliterative bronchiolitis; PDGF; TGF

Indexed keywords

CELL MARKER; CONNECTIVE TISSUE GROWTH FACTOR; IMATINIB; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; CYTOKINE RELEASE; HISTOLOGY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALS; BRONCHI; BRONCHIOLITIS OBLITERANS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GRAFT REJECTION; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; PIPERAZINES; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-SIS; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SUS SCROFA; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34547890687     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140701539745     Document Type: Article

References (46)

1. Trulock E, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI: The Registry of the International Society for Heart and Lung Transplantation: Twenty first Official adult lung and heart-lung transplant report - 2004. J Heart Lung Transplant. 2004;23:804-815.
2. Milne DS, Gascoigne A, Wilkes J, Sviland L, Ashcroft T, Pearson AD, Malcolm AJ, Corris P: The immunohistopathology of obliterative bronchiolitis following lung transplantation. Transplantation. 1992;54:748-750.
3. Mauck KA, Hosenpud JD: The bronchial epithelium: a potential allogeneic target for chronic rejection after lung transplantation. J Heart Lung Transplant. 1996;15:709-714.
4. Estenne M, Hertz MI: Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med. 2002;166:440-444.
5. Hertz MI, Henke CA, Nakhleh RE, Harmon KR, Marinelli WA, Fox JM, Kubo SH, Shumway SJ, Bolman RM 3rd, Bitterman PB: Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet derived growth factor. Proc Natl Acad Sci USA 1992;89:10385-10389.
6. Kallio E, Koskinen PK, Aavik E, Buchdunger E, Lemstrom K: Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the rat. Am J Respir Crit Care Med. 1999;160:1324-1332.
7. El-Gamel A, Sim E, Hasleton P, Hutchinson J, Yonan N, Egan J, Campbell C, Rahman A, Sheldon S, Deiraniya A, Hutchinson IV: Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant. 1999;18:828-837.
8. Aris RM, Walsh S, Chalermskulrat W, Hathwar V, Neuringer IP: Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am J Respir Crit Care Med. 2002;166:417-422.
9. Heldin CH, Westermark B: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283-1316.
10. Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldin CH, Alitalo K, Eriksson U: PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol. 2001;3:512-516.
11. Heldin CH, Eriksson U, Ostman A: New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys. 2002;398:284-290.
12. Border WA, Noble NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
13. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR: Stimulation of fibroblast cell growth, matrix production and granulation tissue formation by connective tissue growth factor. J Invest Dermal. 1996;107:404-411.
14. Tikkanen JM, Krebs R, Bruggeman C, Lemstrom KB, Koskinen PK: Platelet-derived growth factor regulates cytomegalovirus infection-enhanced obliterative bronchiolitis in rat tracheal allografts. Transplantation. 2003;77:655-658.
15. Ramirez AM, Takagawa S, Sekosan M, Raffe HA, Varga J, Roman J: Smad3 deficiency ameliorates experimental obliterative bronchiolitis in a heterotopic tracheal transplantation model. Am J Pathol. 2004;165:1223-1232.
16. Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ, Lydon NB: Abl protein -tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther. 2000;295:139-145.
17. George D: Targeting PDGF receptors in cancer-rationales and proof of concept clinical trials. Adv Exp Med Biol. 2003;532:141-151.
18. Savikko J, Taskinen E, von Willebrand E: Chronic allograft nephropathy is prevented by inhibition of PDGF receptor: tyrosine kinase inhibitors as a potential therapy. Transplantation. 2003;75:1147-1153.
19. Sihvola RK, Tikkanen JM, Krebs R, Aaltola EM, Buchdunger E, Laitinen O, Koskinen PK, Lemstrom KB: Platelet-derived growth factor inhibition reduces allograft arteriosclerosis of heart and aorta in cholesterol-fed rabbits. Transplantation. 2003;75:334-339.
20. Nykänen AI, Krebs R, Tikkanen JM, Raisky O, Sihvola R, Wood J, Koskinen PK, Lemstrom KB: Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. Transplantation. 2005;79:182-189.
21. Krebs R, Tikkanen JM, Nykänen AI, Wood J, Jeltsch M, Yla-Herttuala S, Koskinen PK, Lemstrom KB: Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis. Am J Respir Crit Care Med. 2005;171:1421-1429.
22. Ikonen T, Uusitalo M, Taskinen E, Korpela A, Salminen US, Morris RE, Harjula AL: Small airway obliteration in a new swine heterotopic lung and bronchial allograft model. J Heart Lung Transplant. 1998;17:945-953.
23. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL: Efficacy and safety of a specific inhibitor of the BCRABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001;344:1031-1037.
24. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R: TGF-β1 induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 1990;63:515-524.
25. Xie S, Sukkar MB, Issa R, Oltmanns U, Nicholson AG, Chung KF: Regulation of TGF-β1-induced connective tissue growth factor (CTGF) expression in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2005;288:L68-L76.
26. Nishishita T, Lin PC: Angiopoietin 1, PDGF-BB, and TGF-beta gene regulation in endothelial cell and smooth muscle cell interaction. J Cell Biochem. 2004;91:584-593.
27. Igarashi A, Okochi H, Bradham DM, Grotendorst GM: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Cell Biol. 1993;4:637-645.
28. Oemar BS, Werner A, Garnier JM, Do DD, Godoy N, Nauck M, Marz W, Rupp J, Pech M, Luscher TF: Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation. 1997;95:831-839.
29. Rubin K, Tingström A, Hansson GK, Larsson E, Ronnstrand L, Klareskog L, Claesson-Welsh L, Heldin CH, Fellstrom B, Terracio L: Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet. 1988;1:1353-1356.
30. Savikko J, Kallio EA, Willebrand E: Early induction of platelet-derived growth factor ligands and receptors in acute rat renal allograft rejection. Transplantation. 2001;72:31-37.
31. Charpin JM, Valcke J, Kettaneh L, Epardeau B, Stern M, Israel-Biet D: Peaks of transforming growth factor-beta mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection. Transplantation. 1998;65:752-755.
32. Moussad EEA, Brigstock DR: Connective tissue growth factor: what's in a name? Mol Genet Metab. 2000;71:276-292.
33. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol. 2000;11:25-38.
34. Cwynarski K, Laylor R, Macchiarulo E, Goldman J, Lombardi G, Melo JV, Dazzi F: Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia. 2004;18:1332-1339.
35. Dietz AB, Souan L, Knutson GJ, Bulur PA, Litzow MR, Vuk-Pavlovic S: Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. Blood. 2004;104:1094-1099.
36. Appel S, Boehmler AM, Grünebach F, Muller MR, Rupf A, Weck MM, Hartmann U, Reichardt VL, Kanz L, Brummendorf TH, Brossart P: Imatinib mesylate affects the development and function of dendritic cells generated from CD34p peripheral blood progenitor cells. Blood. 2004;103:538-544.
37. Brody AR, Bonner JC, Overby LH, Badgett A, Kalter V, Kumar RK, Bennett RA: Interstitial pulmonary macrophages produce platelet-derived growth factor that stimulates rat lung fibroblast proliferation in vitro. J Leukoc Biol. 1992;51:640-648.
38. Krettek A, Östergren-Lundel G, Fager G, Rosmond C, Bondjers G, Lustig F: Expression of PDGF receptors and ligand-induced migration of partially different human monocyte-derived macrophages. Influence of IFN-γ and TGF-β. Atherosclerosis. 2001;156:267-275.
39. Daynes RA, Dowell T, Araneo BA: Platelet-derived growth factor is a potent biologic response modifier of T cells. J Exp Med. 1991;174:1323-1333.
40. Morisaki N, Takahashi K, Shiina R, Zenibayashi M, Otabe M, Yoshida S, Saito Y: Platelet-derived growth factor is a potent stimulator of expression of intercellular adhesion molecule-1 in human arterial smooth muscle cells. Biochem Biophys Res Commun. 1994;200:612-618.
41. Oyaizu T, Okada Y, Shoji W, Matsumura Y, Shimada K, Sado T, Sato M, Kondo T: Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation. Transplantation. 2003;76:1214-1220.
42. Cruz AC, Hall TS, Jones KD, Edwards ST, Fang KC: Induction of mast cell activation and CC chemokine responses in remodeling tracheal allografts. Am J Respir Cell Mol Biol. 2004;31:154-161.
43. Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB: Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest. 2004;114:1308-1316.
44. Aono Y, Nishioka Y, Inayama M, Ugai M, Kishi J, Uehara H, Izumi K, Sone S: Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 2005;171:1279-1285.
45. Maasilta PK, Salminen US, Lautenschlager IT, Taskinen EI, Harjula AL: Immune cells and immunosuppression in a porcine bronchial model of obliterative bronchiolitis. Transplantation. 2001;72:998-1005.
46. Tikkanen JM, Hollmen M, Nykänen AI, Wood J, Koskinen PK, Lemström KB: Role of platelet-derived growth factor and vascular endothelial growth factor in obliterative airway disease. Am J Respir Crit Care Med. 2006;174:1145-1152.